Autopsy report · NCT00728091
A Phase III Study Evaluating the Efficacy and Safety of Satavaptan Versus Placebo in Patients With Dilutional Hyponatremia
Cause of deathNo reason given
Life of this trial
- Ran for about 5 months before it stopped.
- 2 participants enrolled.
- No results are posted on the registry.
Vital statistics
- Status
- Terminated
- Phase
- Phase 3
- Sponsor
- Sanofi
- Sponsor type
- Industry
- Conditions
- Hyponatremia; Inappropriate ADH Syndrome
- Interventions
- Satavaptan; placebo
- Participants
- 2
- Sites
- 1
- Countries
- United States
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.